Wells Fargo & Company Kamada LTD Transaction History
Wells Fargo & Company
- $433 Billion
- Q4 2024
A detailed history of Wells Fargo & Company transactions in Kamada LTD stock. As of the latest transaction made, Wells Fargo & Company holds 630,688 shares of KMDA stock, worth $4.91 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
630,688
Previous 629,884
0.13%
Holding current value
$4.91 Million
Previous $3.38 Million
13.54%
% of portfolio
0.0%
Previous 0.0%
Shares
19 transactions
Others Institutions Holding KMDA
# of Institutions
27Shares Held
6.18MCall Options Held
200Put Options Held
0-
Phoenix Holdings Ltd. Givatayim, L31.83MShares$14.3 Million0.16% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.4MShares$10.9 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny832KShares$6.48 Million0.01% of portfolio
-
Y.D. More Investments LTD Ramat Gan, L3499KShares$3.89 Million0.27% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny318KShares$2.48 Million0.0% of portfolio
About KAMADA LTD
- Ticker KMDA
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 44,800,500
- Market Cap $349M
- Description
- Kamada Ltd. provides plasma-derived protein therapeutics. It operates in two segments, Proprietary Products and Distribution. The company offers KAMRAB/KEDRAB for prophylaxis of rabies disease; CYTOGAM for prophylaxis of cytomegalovirus disease in kidney, lung, liver, pancreas, heart, and heart/lung transplant; WINRHO SDF for immune thrombocytop...